N-IP-00001

N-IP-00001 · NeoTrials Pty Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for N-IP-00001, covering 2025-02-04 to 2025-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Safety Study of Inhaled N-IP-00001 to Determine Tolerability and Safety in Healthy Volunteers. [Phase 1]